Company Filing History:
3 out of 5 
2 out of 54 
1 out of 33 
Years Active: 2016-2020
Title: Catherine Guette: Innovator in Breast Cancer Management
Introduction
Catherine Guette is a prominent inventor based in La Possonniere, France. She has made significant contributions to the field of breast cancer management through her innovative research and patented inventions. With a total of 3 patents, her work focuses on improving the diagnosis and prognosis of breast cancer, particularly triple-negative breast cancer.
Latest Patents
Catherine Guette's latest patents include groundbreaking methods for diagnosing and prognosing the recurrence of triple-negative breast cancer. Her first patent addresses the technical field of breast cancer management, specifically focusing on the identification of biomarkers that are abnormally expressed in patients experiencing a recurrence of this aggressive form of cancer. This invention highlights the relationship between these biomarkers and patient survival.
Another significant patent involves the identification of olfactomedin-4, neudesin, and desmoplakin as biomarkers of breast cancer. This invention aims to enhance the diagnostic process for breast cancer by utilizing these specific biomarkers found in the blood of patients.
Career Highlights
Catherine has worked with esteemed organizations such as the Institut de Cancérologie de l'Ouest and the Université d'Angers. Her experience in these institutions has allowed her to collaborate with leading experts in the field and contribute to advancements in cancer research.
Collaborations
Throughout her career, Catherine has collaborated with notable colleagues, including Olivier Coqueret and Benjamin Barre. These partnerships have further enriched her research and innovation efforts in breast cancer management.
Conclusion
Catherine Guette's contributions to breast cancer management through her innovative patents demonstrate her commitment to improving patient outcomes. Her work in identifying critical biomarkers is paving the way for more effective diagnostic and prognostic methods in the fight against breast cancer.